Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy
- PMID: 35225964
- PMCID: PMC8883961
- DOI: 10.3390/jdb10010011
Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy
Abstract
Lymphatic malformations are fluid-filled congenital defects of lymphatic channels occurring in 1 in 6000 to 16,000 patients. There are various types, and they often exist in conjunction with other congenital anomalies and vascular malformations. Great strides have been made in understanding these malformations in recent years. This review summarize known molecular and embryological precursors for lymphangiogenesis. Gene mutations and dysregulations implicated in pathogenesis of lymphatic malformations are discussed. Finally, we touch on current and developing therapies with special attention on targeted biotherapeutics.
Keywords: PI3CKA; cystic hygroma; lymphatic malformation.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- Fishman S.J., Young A.E. Slow-Flow Vascular Malformations. Oxford University Press; Oxford, UK: 2013.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
